Effects of EDP-938 in Hematopoietic Cell Transplant Recipients Infected With Respiratory Syncytial Virus of the Upper Respiratory Tract

NCT04633187 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated due to a strategic business decision and not due to safety concerns.

Conditions

Interventions

Sponsor

Enanta Pharmaceuticals, Inc